Evidence map›Paper›PMID 27115337›Full record

ArticleJournal of hypertension2016

Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.

Francesco Dalle Vedove, Cristiano Fava, Houli Jiang, Giovanni Zanconato, John Quilley, Matteo Brunelli, Valeria Guglielmi, Gaetano Vattemi, Pietro Minuz

Open access · greenAbstract read
In one paragraph

Article in Journal of hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Francesco Dalle VedoveaDepartment of Medicine, Verona, Italy bDepartment of Pharmacology, New York Medical College, Valhalla, New York, USA cDepartment of Surgical Sciences, Dentistry, Gynecology and Pediatrics dDepartment of Diagnostics and Public Health eDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy *These authors contributed equally to the study.
Cristiano Fava
Houli Jiang
Giovanni Zanconato
John Quilley
Matteo Brunelli
Valeria Guglielmi
Gaetano Vattemi
Pietro Minuz
Apple (Israel) · ILUniversity of Verona · IT

Funding

Vasoregulatory Function of CYP2E1-Derived EicosanoidsP01HL034300 · NHLBI · NEW YORK MEDICAL COLLEGE · PI SCHWARTZMAN, MICHAL LANIADO · 1985 to 2015
$33.4M
NHLBI NIH HHS P01 HL034300
6 · The paper itself

Abstract

backgroundEpoxyeicosatrienoic acids (EETs) derived from cytochrome P450 (CYP)-dependent metabolism of arachidonic acid are increased in the plasma of women with preeclampsia as compared with normal pregnancy and are significantly higher in fetal than in maternal plasma and erythrocytes. We hypothesized that differences in EET synthesis or metabolism in the feto-placental unit contributed to the observed differences in circulating EETs.

methodTo evaluate EETs, formation as well as the expression of relevant CYP isoforms and the metabolizing enzyme, soluble epoxide hydrolase (sEH), biopsies of placenta were collected from 19 normal pregnancy and 10 preeclampsia at the time of cesarean section delivery. EETs were extracted from tissue homogenates and analyzed by liquid chromatography coupled with tandem mass spectrometry.

resultsBoth cis-EETs and trans-EETs were detected in the placenta. Concentration of total EETs was higher in the placenta from preeclampsia compared with normal pregnancy (2.37 ± 1.42 ng/mg vs. 1.20 ± 0.72 ng/mg, mean ± SD, P < 0.01), especially the 5,6-, 8,9- and 11,12-EETs, measured in a subgroup of tissue samples (normal pregnancy = 10, preeclampsia = 5). By immunohistochemistry, sEH, CYP2J2, CYP4A11 were present in placental villi with different pattern distribution, whereas CYP2C8 was not detectable. Neither were CYP2J2, CYP4A11, and CYP2C8 detected in the umbilical cord. Western blot analysis of placenta homogenates showed reduced expression of sEH in preeclampsia as compared with normal pregnancy.

conclusionIncreased EETs in the placenta and umbilical cord are associated with the presence of CYP2J2, whereas reduced expression of sEH in preeclampsia may be the key factor of increased EETs in the placenta.

Indexed as

8,11,14-Eicosatrienoic AcidAdultAnimalsCase-Control StudiesCytochrome P-450 CYP2C8Cytochrome P-450 CYP2J2Cytochrome P-450 CYP4ACytochrome P-450 Enzyme SystemEicosanoidsEpoxide HydrolasesEpoxy CompoundsErythrocytesFemaleFetusHumansImmunohistochemistry8,11,14-Eicosatrienoic AcidCYP2J2 protein, humanCYP4A11 protein, humanCytochrome P-450 CYP2C8Cytochrome P-450 CYP2J2Cytochrome P-450 CYP4ACytochrome P-450 Enzyme SystemEicosanoidsEpoxide HydrolasesEpoxy Compounds

Identifiers

PMID27115337
PMCPMC5559898
OpenAlexW2345123624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.